Wyeth & Elan: More Questions in Alzheimer's Study Results (WYE, ELN)
Today was the long awaited Alzheimer’s drug data presented from Elan Corporation, plc (NYSE: ELN) and Wyeth (NYSE: WYE). The companies presented detailed results from their 18-month Phase II study of...
View ArticlePrana Scores Alzheimer's Disease US Patent Protection (PRAN)
Prana Biotechnology (Nasdaq:PRAN) has received a key patent that will allow it to have more protection for its Alzheimer’s candidate. The company said it received a Notice of Allowance from the United...
View ArticleBiogen Idec Invests In Alzheimer’s Disease (BIIB)
It seems that Biogen Idec Inc. (NASDAQ: BIIB) is investing further into Alzheimer’s Disease. A company called Probiodrug AG, a biotech with a particular focus on Alzheimer’s disease, announced on...
View ArticlePfizer Outlines New Drug R&D Pipeline (PFE, MRK, NVS, GSK)
Pfizer Inc. (NYSE: PFE) is making a pipeline presentation today, and it is meant to address a serious and potentially severe issue affecting all Big Pharma companies from Merck & Co. (NYSE: MRK)...
View ArticleBiotech Implosion: Medivation, Alzheimer’s Beats Drug (MDVN, PFE)
Medivation, Inc. (NASDAQ: MDVN) is the next biotech implosion. The company’s highly awaited Phase III study on its Alzheimer drug called Dimebon did not meet expectations. It failed to meet primary...
View ArticleTalking Biotech ETFs: iShares Nasdaq Biochnology to $100 (IBB, OSIP, MDVN)
Today’s price moves in the biotech sector are quite different from what we saw earlier this week. A hostile merger via tender from Astellas for OSI Pharmaceuticals Inc. (NASDAQ: OSIP) got everyone up...
View ArticleTen-Bagger Chase Goes After Prana (PRAN)
Prana Biotechnology Ltd. (NASDAQ: PRAN) is up over 100% today on some published data. The share trading activity is indicative of traders and investors looking for the next biotech ten-bagger, or that...
View ArticleNymox Moves Following Singular Research Report
Nymox Pharmaceutical Corporation (NASDAQ: NYMX) was up $0.59 (15.32%) today to $4.44 following a Singular Research report in which the company was predicted to obtain greater value in the coming months...
View ArticleMerck Commits To New Alzheimer’s-Focused Collaboration
In an effort to combat Alzheimer’s disease, global health care giant Merck & Company, Inc. (NYSE: MRK) has entered into a deal for $289 million with Canada’s Alectos Therapeutics to develop new...
View ArticleClik here to view.
Prana: A Speculative Ten-Bagger Scenario (PRAN)
This last week brought an interesting move in shares of Prana Biotechnology Ltd. (NASDAQ: PRAN). On Friday we gave this coverage right at the open noting at 24/7 Wall Street that the stock was still...
View Article
